SARS-CoV-2 neutralization and protection of hamsters via nasal administration of a humanized neutralizing antibody

Related articles

1. A Novel Inactivated Vaccine Based on an Emerging PEDV GIIc Variant Provides Broad Cross-Protection Against Heterologous Strains

   This article has 10 authors:

   1. Jingjing Xu
   2. Ningning Fu
   3. Zimin Liu
   4. Mengli Chen
   5. Guijun Ma
   6. Hehai Li
   7. Jianghui Wang
   8. Bo Yin
   9. Zhen Zhang
   10. Feifei Diao

2. Fusion protein pan-sarbecovirus vaccines elicit broadly protective immune responses targeting Clade 1a, 1b, and 3 sarbecoviruses

   This article has 28 authors:

   1. Alyson Kelvin
   2. Matthew Rogers
   3. Zahed Katooni
   4. Eva-Maria Uhlemann
   5. Rachelle Buchanan
   6. Erin Scruten
   7. Anthony Yourkowski
   8. Jocelyne Lew
   9. Akarin Asavajaru
   10. Jill Van Kessel
   11. Paul Pennington
   12. Andrea Kroeker
   13. Cynthia Swan
   14. Rinku Patel
   15. Brittany Thivierge
   16. Willian Deck
   17. Ravendra Garg
   18. Glenn Hamonic
   19. Wolfgang Koster
   20. Tracy Prysliak
   21. Anne-Catherine Fluckiger
   22. Jasminka Bozic
   23. Andrew Van Kessel
   24. Volker Gerdts
   25. Qiang Liu
   26. Arinjay Banerjee
   27. Darryl Falzarano
   28. Trina Racine

3. Preparation and epitope mapping of broad-spectrum neutralizing monoclonal antibodies against economically important pestiviruses

   This article has 12 authors:

   1. Zhongdi Liu
   2. Shijiang Mi
   3. Sun He
   4. Meng Wu
   5. Fei Bao
   6. Ye Feng
   7. Zunbao Wang
   8. Longfei Xu
   9. Xiaomei Pan
   10. Changchun Tu
   11. Junhui Li
   12. Wenjie Gong